Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
8
×
life sciences
national
8
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
8
×
texas top stories
wisconsin blog main
wisconsin top stories
biotech
clinical trials
indiana blog main
indiana top stories
cancer
eli lilly
ipo
cancer immunotherapy
drugs
gene therapy
merck
nivolumab
renaissance capital
abbvie
aimmune therapeutics
What
week
8
×
bio
roundup
ipo
life
science
companies
moves
big
biotechs
firms
medical
public
rolls
therapeutics
alzheimer’s
america
american
annual
arena’s
ash
assessed
attention
biogen
biotech
black
blood
bosley's
bosley’s
bounty
bridge
bucks
cas
ceo
chose
cig
close
club
comeback
communities
Language
unset
Current search:
national
×
week
×
" texas blog main "
×
fda
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M